Healthcare entity
All 1 tracked stories fall under one category: market-trends. Crinetics is most often covered alongside Baldwin, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 3.2 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.7 for that window.
Last mentioned: Feb 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Crinetics is most often covered alongside Baldwin, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 3.2 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.7 for that window. Crinetics appears in 1 tracked Healthcare story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Crinetics. Shared-story counts are live from our verified record — not editorial picks.
The Q4 2025 earnings reports from Crinetics, MDxHealth, and Baldwin highlight a pivotal shift toward precision diagnostics and specialized endocrine therapies. These results underscore a robust recovery in diagnostic volumes and a maturing pipeline for rare disease treatments entering commercialization phases.
Source: seekingalpha.com · flipboard.com
Crinetics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
